Related Experiment Video

Updated: Jul 3, 2026

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
07:21

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

Gastrointestinal stromal tumors (GISTs): from science to targeted therapy

R Sarmiento1, P Bonginelli, F Cacciamani

  • 1Division of Medical Oncology, San Filippo Neri Hospital, Rome - Italy.

The International Journal of Biological Markers
|July 17, 2008
PubMed

Insights

Gastrointestinal stromal tumors (GISTs) are common mesenchymal tumors driven by KIT mutations. Targeted therapies like imatinib and sunitinib offer effective treatment for GISTs, with KIT mutations guiding therapy selection.

Area of Science:

  • Gastrointestinal oncology
  • Molecular pathology
  • Pharmacogenomics

Background:

  • Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.
  • GISTs are characterized by oncogenic mutations in the KIT receptor tyrosine kinase.
  • KIT mutations are crucial for GIST diagnosis and targeted therapy.

Purpose of the Study:

  • To review the biology and molecular patterns of GISTs.
  • To focus on the predictive value of KIT mutations and their clinical outcome correlation.
  • To discuss the activity of and resistance to approved targeted drugs for GISTs.

Main Methods:

  • Review of scientific literature on GISTs.
  • Analysis of KIT mutation patterns and their clinical significance.
  • Evaluation of targeted therapies including imatinib and sunitinib.

Main Results:

  • KIT mutations are found in a majority of GIST patients.
  • Imatinib revolutionized advanced GIST treatment and shows promise in neoadjuvant/adjuvant settings.
  • Sunitinib is approved for imatinib-resistant GISTs, expanding treatment options.

Conclusions:

  • KIT mutations are key determinants of GIST behavior and response to therapy.
  • Targeted therapies have significantly improved outcomes for advanced and resistant GISTs.
  • Understanding molecular patterns is essential for personalized GIST treatment strategies.

More Related Videos

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib06:43

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Published on: April 3, 2026

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...